TY  - GEN
AU  - Richel,D J
AU  - Johnsen,H E
AU  - Canon,J
AU  - Guillaume,T
AU  - Schaafsma,M R
AU  - Schenkeveld,C
AU  - Hansen,S W
AU  - McNiece,I
AU  - Gringeri,A J
AU  - Briddell,R
AU  - Ewen,C
AU  - Davies,R
AU  - Freeman,J
AU  - Miltenyi,S
AU  - Symann,M
TI  - Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients
SN  - 0268-3369
PY  - 2000///0411
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Animals
KW  - Antibodies
KW  - blood
KW  - Antigens, CD34
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - CD4-CD8 Ratio
KW  - Cell Survival
KW  - Equipment Failure
KW  - Female
KW  - Graft Survival
KW  - Humans
KW  - Immunomagnetic Separation
KW  - instrumentation
KW  - Leukapheresis
KW  - standards
KW  - Lymphocyte Count
KW  - Mice
KW  - immunology
KW  - Middle Aged
KW  - Survival Rate
KW  - Time Factors
KW  - Transplantation, Autologous
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study
UR  - https://doi.org/10.1038/sj.bmt.1702136
ER  -